Carlsmed (CARL) Gross Profit (2024 - 2026)

Carlsmed (CARL) has reported Gross Profit for 3 consecutive years, with $14.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Gross Profit rose 63.96% year-over-year to $14.5 million; the trailing twelve-month figure through Jun 2026 stood at $48.5 million (up 71.22% YoY), and the FY2025 full-year result was $38.0 million, up 89.74% from the prior year.
• Gross Profit rose to $14.5 million in Q2 2026 per CARL's latest filing, from $12.4 million in the prior quarter.
• Across five years, Gross Profit topped out at $14.5 million in Q2 2026 and bottomed at $4.6 million in Q2 2024.
• Historically, Gross Profit has averaged $9.0 million across 3 years, with a median of $8.9 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Gross Profit jumped 106.9% in 2025, then jumped 62.72% in 2026.
• Over 3 years, Gross Profit stood at $7.0 million in 2024, then soared by 65.26% to $11.6 million in 2025, then increased by 25.28% to $14.5 million in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $14.5 million, $12.4 million, and $11.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.